- IHH Healthcare (SGX:Q0F)'s 1Q24 core profit of MYR402.8m accounted for 25% and 24% of our and Street’s expectation. Results were in line, aided by sustained demand for healthcare services, a better case mix, and timely price adjustments to counter inflationary pressure.
- - Read this at SGinvestors.io -
Results overview.
- Revenue from the hospital & healthcare (H&H) division reported 19% y-o-y growth to MYR5.6bn on consolidation of newly acquired entities Kent Health Group (Feb 2023) and Timberland Medical Centre (Feb 2024) on top of other factors. Sequentially, the H&H wing grew 8% q-o-q on higher revenue intensity across regions and inpatient admission volumes (except for Malaysia due to the Aidil Fitri festivities).
- - Read this at SGinvestors.io -
- Operational beds were largely flat y-o-y and q-o-q at 12,166. IHH Healthcare’s bed occupancy rate (BOR) contracted slightly to 70% (1Q23: 71%).
Segmental breakdown.
- Read more at SGinvestors.io.
Oong Chun Sung RHB Securities Research | https://www.rhbgroup.com/ 2024-05-30
Previous report by RHB:
2024-03-05 IHH Healthcare - Thriving In All Regions; Keep BUY.
Price targets by other brokers at IHH Healthcare Target Prices.
Listing of research reports at IHH Healthcare Analyst Reports.
Relevant links:
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividends & Corporate Actions,
IHH Healthcare News Articles